Top Story

Atlas Global Brands Provides Corporate Update and Outlines Growth Strategy
June 7th, 2023 - Ryan Allway
trong execution since going public on the Canadian Securities Exchange (the “CSE”) in January 2023 Atlas launches D*gg Lbs brand in collaboration with Snoop Dogg, firs...
Top News

Red White & Bloom and Aleafia Health Execute Binding Letter Agreement for Business Combination
June 7th, 2023 - Ryan Allway

Atlas Global Brands Provides Corporate Update and Outlines Growth Strategy
June 7th, 2023 - Ryan Allway

Dablicator Retail Revenues Surpass $100MM as it Enters Brand Partnership with TerrAscend
May 31st, 2023 - Ryan Allway

Hill Incorporated Releases FY2023 Q3 Financial Results
May 31st, 2023 - Ryan Allway
Public Companies
Private Companies & Entrepreneurs
Cannabis & CBD

Red White & Bloom and Aleafia Health Execute Binding Letter Agreement for Business Combination
June 7th, 2023 - Ryan Allway

Atlas Global Brands Provides Corporate Update and Outlines Growth Strategy
June 7th, 2023 - Ryan Allway

Dablicator Retail Revenues Surpass $100MM as it Enters Brand Partnership with TerrAscend
May 31st, 2023 - Ryan Allway

Red White & Bloom Reports Results for the Three Months Ended March 31, 2023
May 31st, 2023 - Ryan Allway

Cansortium Reports First Quarter 2023 Results
May 31st, 2023 - Ryan Allway

Hill Incorporated Releases FY2023 Q3 Financial Results
May 31st, 2023 - Ryan Allway

Adastra Holdings Reports First Quarter Results; Demonstrating Record Quarterly Gross Revenues of $9.5M
May 30th, 2023 - Ryan Allway

AYURCANN REPORTS RECORD SALES OF $5,893,351 FOR Q3 2023, AN INCREASE OF 114% OVER Q3 2022
May 29th, 2023 - Ryan Allway
Psychedelics & Mushrooms

Kaya Holdings, Inc.’s V.P. Bryan Arnold Among First Ten (10) State Licensed Psilocybin Facilitators in U.S.A.
May 24th, 2023 - Ryan Allway

Clearmind Medicine Announces Pricing of US$3.5 Million Public Offering
April 4th, 2023 - Ryan Allway

Doseology Announces CEO Transition
March 31st, 2023 - Ryan Allway

Silo Wellness Eliminates Another CAD$4,440,000 of Debt from Balance Sheet by Disposing of Subsidiary
March 28th, 2023 - Ryan Allway

Clearmind Medicine Submits IND Application to FDA for its Proprietary CMND-100 Treating Alcohol Use Disorder
March 16th, 2023 - Ryan Allway

Israel-Based Clearmind Medicine Files Patent Applications for Three Unique Combinations of Future Psychedelic-Based Compounds
February 22nd, 2023 - Ryan Allway
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer